StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3011% below fair value
$0.94−0.07 (-6.71%)

Close on Nov 20, 2026Market cap $94.41MP/E –Yield –

Stereotaxis shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Stereotaxis's shares outstanding was 100M at Jun 30, 2026. For fiscal 2025 it was 91M, up 6.8% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is 91M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202591M+6.8%
FY2024Dec 31, 202485M+5.6%
FY2023Dec 31, 202381M+6.1%
FY2022Dec 31, 202276M+0.7%
FY2021Dec 31, 202176M+3.9%
FY2020Dec 31, 202073M+15.4%
FY2019Dec 31, 201963M+21.1%
FY2018Dec 31, 201852M+130.3%
FY2017Dec 31, 201723M+3.7%
FY2016Dec 31, 201622M+3.3%
FY2015Dec 31, 201521M+5.9%
FY2014Dec 31, 201420M+72.6%
FY2013Dec 31, 201312M+66.4%
FY2012Dec 31, 20127M+26.7%
FY2011Dec 31, 20115M+8.5%
FY2010Dec 31, 20105M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026100M+13.7%
Q1 FY2026Mar 31, 202699M+12.7%
Q4 FY2025Dec 31, 202596M+10.6%
Q3 FY2025Sep 30, 202592M+7.2%
Q2 FY2025Jun 30, 202588M+4.0%
Q1 FY2025Mar 31, 202588M+5.1%
Q4 FY2024Dec 31, 202487M+5.0%
Q3 FY2024Sep 30, 202486M+4.1%
Q2 FY2024Jun 30, 202485M+4.3%
Q1 FY2024Mar 31, 202483M+9.1%
Q4 FY2023Dec 31, 202383M+8.4%
Q3 FY2023Sep 30, 202382M+8.4%
Q2 FY2023Jun 30, 202381M+6.7%
Q1 FY2023Mar 31, 202377M+0.8%
Q4 FY2022Dec 31, 202276M+0.7%
Q3 FY2022Sep 30, 202276M+0.5%
Q2 FY2022Jun 30, 202276M+0.5%
Q1 FY2022Mar 31, 202276M+0.9%
Q4 FY2021Dec 31, 202176M+1.1%
Q3 FY2021Sep 30, 202176M+1.6%
Q2 FY2021Jun 30, 202176M+5.5%
Q1 FY2021Mar 31, 202175M+7.6%
Q4 FY2020Dec 31, 202075M+10.3%
Q3 FY2020Sep 30, 202074M+15.9%
Q2 FY2020Jun 30, 202072M+19.3%
Q1 FY2020Mar 31, 202070M+18.0%
Q4 FY2019Dec 31, 201968M+15.0%
Q3 FY2019Sep 30, 201964M+9.0%
Q2 FY2019Jun 30, 201960M+1.9%
Q1 FY2019Mar 31, 201959M+78.7%
Q4 FY2018Dec 31, 201859M+159.3%
Q3 FY2018Sep 30, 201859M+159.4%
Q2 FY2018Jun 30, 201859M+161.0%
Q1 FY2018Mar 31, 201833M+48.3%
Q4 FY2017Dec 31, 201723M+3.9%
Q3 FY2017Sep 30, 201723M+4.0%
Q2 FY2017Jun 30, 201723M–
Q1 FY2017Mar 31, 201722M–
Q4 FY2016Dec 31, 201622M–
Q3 FY2016Sep 30, 201622M–

More Stereotaxis figures

See a number that looks wrong?